Sort
261,768 grants matching “gene therapy”
Mixed chimerism induced tolerance in heart recipients requires donor kidney cotransplantation
$858,721Joren C Madsen · Massachusetts General Hospital · U01 · FY2017 · AI
Mixed chimerism induced tolerance in heart recipients requires donor kidney cotransplantation
$858,721Joren C Madsen · Massachusetts General Hospital · U01 · FY2020 · AI
Mixed chimerism induced tolerance in heart recipients requires donor kidney cotransplantation
$858,721Joren C Madsen · Massachusetts General Hospital · U01 · FY2021 · AI
Epigenetics, Stem Cells, and Cancer
$858,663Rudolf Jaenisch · Whitehead Institute For Biomedical Res · R01 · FY2007 · CA
TMEM, MENAcalc, and MENAINV as Prognostic and Predictive Markers for Breast Cancer Metastasis
$858,638Thomas E Rohan · Albert Einstein College Of Medicine · R01 · FY2022 · CA
Study of CAR T cells and mechanisms of resistance in pediatric brain tumors
$858,635Anandani Nellan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
A therapeutic vaccine for chronic hepatitis B
$858,609David R. Milich · Vlp Biotech, Inc. · R44 · FY2020 · AI
Signal Processing And Instrumentation Section
$858,600Thomas J Pohida · Center For Information Technology · ZIA · FY2013 · CT
Role of Adaptive Immunity in Etiology of Alzheimerâs Disease andAlzheimerâs Disease-Related Dementias
$858,590Douglas C Wallace · Children'S Hosp Of Philadelphia · R01 · FY2022 · AG
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV
$858,575John C He · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · DK
Inflammation of Myofibroblasts and Loss of Elastic Recoil in Severe Asthma
$858,566Sally E Wenzel · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · HL
Center for the Study of Innate Immunity to HCV Infection
$858,518Michael J Gale · University Of Washington · U19 · FY2014 · AI
Center for the Study of Innate Immunity to HCV Infection
$858,518Michael J Gale · University Of Washington · U19 · FY2012 · AI
Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy
$858,502Joshua Aiden Hill · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Normalization of Sickle Cell Disease bone marrow niche defects by RBC transfusion
$858,450John P Manis · Boston Children'S Hospital · P01 · FY2022 · HL
Normalization of Sickle Cell Disease bone marrow niche defects by RBC transfusion
$858,450John P Manis · Boston Children'S Hospital · P01 · FY2023 · HL
Targeting PD-1 Pathway for Functional Cure of AIDS
$858,361Rama Rao Amara · Emory University · R37 · FY2016 · AI
CANCAN - Kaiser
$858,321Bette J Caan · Kaiser Foundation Research Institute · OT2 · FY2025 · CA
Cytokine Gene Therapy of Cancer - Preclinical Studies
$858,309Walter J Storkus · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · CA
Biophysics of Large Membrane Channels
$858,248Sergey Bezrukov · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
Development of TGF-beta antagonists for cancer therapy
$858,227Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Leucine rich repeat kinase 2 and dominantly inherited Parkinson disease
$858,225Mark Cookson · National Institute On Aging · ZIA · FY2017 · AG
S-Nitrosothiol-Based Rinse/Aerosol Solutions for Treatment/Prevention of Rhinosinusitis (Phase II)
$858,200Joan A Keiser · Nota Laboratories, Llc · R44 · FY2017 · AI
Decoding T cell clonotypes, biology and predictive biomarkers associated with immune checkpoint Myocarditis
$858,186Alexandra-Chloe Villani · Massachusetts General Hospital · R01 · FY2025 · AI
Human Monoclonal Antibodies for Encephalitic Alphaviruses
$858,139James E Crowe · Vanderbilt University Medical Center · R01 · FY2022 · AI